Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade plus Eloxatin in Mesothelioma
NCT00996385Phase 2Unknown
- Sponsor
- Columbia University
- Start
- Sep 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in malignant pleural mesothelioma (MPM), peritoneal mesothelioma, sponsored by Columbia University. Status: unknown.
02
Drugs
bortezomib
03
Conditions
malignant pleural mesothelioma (MPM)peritoneal mesothelioma
Beyond the preview
Go deeper on NCT00996385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996385.